Esperion Therapeutics Inc. (ESPR) Stock Forecast & Predictions

Esperion Therapeutics Inc. ESPR: $28.22

3891 Ranchero Dr Ste 150, Ann Arbor, Michigan, US. | Sector: Manufacturing | Exchange: NASDAQ/NMS (GLOBAL MARKET) | Web: http://www.esperion.com/

  • Market Cap$0.78B
  • Change (52 Weeks)-29.98%
  • Low (52 Weeks)$23.9
  • Esperion Therapeutics Inc. (ESPR) Forecast Based on Technical Analysis


    Neutral
    Based on 16 Technical Indicators where 12.50% are on Buy, 37.50% on Sell, and 50.00% Neutral.

    According to the market data, Esperion Therapeutics Inc. (ESPR) stock price is $28.22 and the 52 weeks low is $23.9, which means the Esperion Therapeutics Inc. stock price is down -29.98% in the last 12 months.

    Esperion Therapeutics Inc. (ESPR) Stock Price is not Trending currently as per the Weekly Chart, which means the price may range between specific high and low levels for the next few months, unless some significant changes take place in the market performance or news.

    Technical Indicators are algorithms that are used mostly by Technical traders to predict the price action of a stock.

    Based on our analysis of 16 technical indicators, 12.50% are indicating that ESPR Stock price might rise further, 37.50% indicating that ESPR Stock price might fall, and 50.00% are in a neutral position.

    Based on these technical algorithms, overall ESPR stock price has a Neutral Signal, which means the stock price has the potential to move either up or down, depending on the nature of consolidating market phase, since majority of indicators are providing a neutral signal.

    Esperion Therapeutics Inc. (ESPR) Stock Forecast By Analysts


    Strong Buy
    Analysts Recommendations for Esperion Therapeutics Inc. (ESPR) is based on 18 Institutional Analyst Ratings where 33.33% are on Strong Buy, 27.78% on Moderate Buy, 27.78% remains on Hold, 0.00% are on Moderate Sell and 11.11% are on Strong Sell.

    Out of 18 Institutional Analysts, majority recommended ESPR stock as Strong Buy. Since most investors and traders follow analyst ratings closely, this can be a potentially driving factor for the future stock price of Esperion Therapeutics Inc..

    Esperion Therapeutics Inc. (ESPR) Stock Price Prediction By Analysts


    HighLowAverage
    $200.55$24.24$66.86
    $66.86136.91% Upside
    Updated: 2021-04-22 00:00:00

    The Average Price target for ESPR set by the institutional analysts is $66.86 where High Estimate is $200.55, Median $37.74 and Low $24.24.

    The average price target for ESPR by Institutional Analysts is $66.86, which is 136.91% Upside from the current price. So according to the Institutional Analysts, ESPR Stock might be a bit undervalued at this stage and there’s potential for upside.

    However, although Institutional Analysts set their price targets after extensive research, they’re not always correct. After all, the market is mostly driven by investors speculation and emotion than just concrete numbers.

    Esperion Therapeutics Inc. (ESPR) Stock Forecasts By Institutional Analysts


    Analyst
    Recommendation
    Action
    Morgan StanleyEqual-WeightInitiated
    NeedhamStrong BuyMaintained
    JefferiesHoldDowngraded
    Goldman SachsSellDowngraded
    B of A SecuritiesNeutralDowngraded
    Credit SuisseOutperformUpgraded
    B of A SecuritiesBuyMaintained
    B of A SecuritiesBuyMaintained
    Credit SuisseNeutralDowngraded
    JefferiesBuyMaintained
    Northland Capital MarketsMarket PerformMaintained
    B of A SecuritiesBuyInitiated
    CitigroupBuyUpgraded
    JP MorganNeutralMaintained
    Northland SecuritiesMarket PerformDowngraded
    NeedhamStrong BuyMaintained
    CitigroupNeutralDowngraded
    Stifel NicolausBuyMaintained
    Goldman SachsNeutralUpgraded
    Goldman SachsSellDowngraded
    Goldman SachsNeutralUpgraded
    JP MorganNeutralUpgraded
    Goldman SachsSellInitiated
    BTIG ResearchBuyInitiated
    CitigroupBuyUpgraded
    Northland SecuritiesMarket PerformDowngraded
    Credit SuisseOutperformMaintained
    JP MorganUnderweightDowngraded
    Deutsche BankBuyMaintained
    Bank of AmericaUnderperformDowngraded
    Chardan CapitalNeutralMaintained
    UBSNeutralMaintained
    JP MorganNeutralMaintained
    CitigroupNeutralDowngraded
    Credit SuisseOutperformInitiated
    Bank of AmericaBuyUpgraded
    JefferiesBuyUpgraded
    Deutsche BankBuyMaintained
    JefferiesHoldInitiated
    Deutsche BankBuyInitiated
    NeedhamStrong BuyMaintained
    Credit SuisseNeutralUpgraded
    CitigroupBuyUpgraded
    CitigroupNeutralDowngraded
    WallachbethHoldDowngraded
    UBSNeutralDowngraded
    RBC CapitalSector PerformDowngraded
    Lake StreetBuyMaintained
    JP MorganNeutralDowngraded
    Credit SuisseUnderperformDowngraded
    CitigroupBuyMaintained
    BarclaysEqual-WeightDowngraded
    JMP SecuritiesMarket OutperformMaintained
    Chardan CapitalNeutralMaintained
    Stifel NicolausBuyMaintained
    BarclaysOverweightMaintained
    Chardan CapitalNeutralUpgraded
    NeedhamStrong BuyUpgraded
    NeedhamStrong BuyUpgraded
    CitigroupBuyMaintained
    Chardan CapitalSellMaintained
    JP MorganOverweightInitiated
    Credit SuisseNeutralDowngraded
    Chardan CapitalSellMaintained
    JMP SecuritiesMarket OutperformMaintained
    Chardan CapitalSellInitiated
    BarclaysOverweightInitiated
    Stifel NicolausBuyMaintained
    RBC CapitalOutperformInitiated
    UBSBuyInitiated
    Stifel NicolausBuyMaintained
    JMP SecuritiesMarket OutperformMaintained
    Bank of AmericaBuyUpgraded
    JMP SecuritiesMarket OutperformMaintained
    Credit SuisseOutperformMaintained
    CitigroupBuyMaintained
    JMP SecuritiesMarket OutperformMaintained
    Credit SuisseOutperformMaintained
    CitigroupBuyMaintained
    Stifel NicolausBuyInitiated
    Credit SuisseOutperformInitiated
    CitigroupBuyInitiated

    Esperion Therapeutics Inc. (ESPR) Stock Earning Per Share (EPS) Forecast / Estimate


    $-2.861
    The average consensus EPS for ESPR is $-2.861 with a high estimate of $-2.615 and Low of $-3.283 for the period 2021-06-30 and based on 13 Institutional Analysts.

    Last Quarter


    Actual
    Estimate
    Date
    $-3.07$-3.5049752020-09-30


    The latest average Earning Per Share Estimate for Esperion Therapeutics Inc. is $-2.86, which is higher than ESPR's last EPS, $-3.07. This means that Analysts are expecting Esperion Therapeutics Inc. to report higher earnings. This can drive share prices higher since the investors have positive sentiment about market performance of Esperion Therapeutics Inc..

    Earning Per Share (EPS) History


    Actual
    Estimate
    Date
    $-3.07$-3.5049752020-09-30
    $4.32$1.74030362020-06-30
    $-2.84$-3.36132842020-03-31
    $-2.26$-2.72303282019-12-31
    $-2.52$-1.988492019-09-30
    $-2.01$-1.8953642019-06-30
    $3.07$0.75038342019-03-31
    $-2.24$-1.4512052018-12-31
    $-1.86$-1.66315080000000022018-09-30
    $-1.71$-1.75263542018-06-30
    $-1.73$-1.5902822018-03-31
    $-1.44$-1.822742017-12-31
    $-1.86$-1.81680362017-09-30
    $-1.92$-1.64106779999999992017-06-30
    $-1.8$-1.45352017-03-31
    $-1.29$-1.2442982016-12-31
    $-0.77$-0.8349722016-09-30
    $-0.62$-0.79481462016-06-30
    $-0.65$-0.753782016-03-31
    $-0.58$-0.6447932015-12-31
    $-0.57$-0.60749162015-09-30
    $-0.55$-0.587012015-06-30
    $-0.56$-0.48820262015-03-31
    $-0.49$-0.558452014-12-31
    $-0.64$-0.69071342014-09-30
    $-0.6$-0.61047000000000012014-06-30
    $-0.51$-0.631382014-03-31
    $-0.63$-0.512552013-12-31
    $-0.34$-0.407492013-09-30
    $-12.54$-0.5408552013-06-30

    What is Analyst Ratings & Price Targets?

    The analysts provide Buy, Sell or Hold ratings after extensive research of a companies financial reports, listening to conference calls and some of them even get in contact with upper management of the company to get an overall picture of operation.

    Although institutional Analyst’s are not always correct, their ratings are followed by millions of traders around the world and they can heavily influence trading activities for a company.

    As a retail investor, going through analyst ratings will instantly provide you an idea if the stock is worth buying. Top Analysts also provide their price targets. It’s a prediction of where the stock price might go based on their analysis.

    The best way to analyze price targets is to combined average price targets of major analysts. If the average price target is much higher than the current price of the stock, then the probability of a stock going up is also high.

    What is Technical Analysis?

    Technical Analysis refers to analyzing a stock's price over a period of time. In the financial market, past price patterns are one of the strongest indicators of an asset's future performance.

    In easier terms, millions of traders use Live Charts to watch the stock prices, it is actually a single source of truth for most traders. When a stock's price reaches a significant price level/pattern in the chart, millions of traders take buy/sell positions from those levels.

    As a regular investor, one of the easiest ways to check technical analysis of a stock is through Technical Indicators. Technical Indicators are programmed algorithms that monitor price changes in the Charts and indicate Buy/Sell based on market conditions.

    Some Technical Indicators can be very powerful (e.g SMA) and some can be pretty useless. Stock research tools like iTradely heavily simplify the technical analysis process for the investors by showing Buy/Sell/Neutral ratings combined from 17 powerful technical indicators, all in one page.

    What is Earnings Per Share (EPS) and Why is it Important?

    EPS, or Earning Per Share, can tell a lot about a stock’s performance. It’s calculated by dividing a company’s profit by the number of outstanding shares of its common stocks.

    In layman’s term, earnings is an indicator of a company’s profitability. Higher the earnings, the more profitable a company is.
    Some traders pick stocks solely based on EPS or earnings Analysis, it is a very powerful indicator of a stock’s price.

    Before you buy a stock, check the company’s earnings History and Surprises. A Surprise happens when a company reports a much higher or lower actual earnings/EPS than the forecasted earnings/EPS.

    If a company reports higher EPS surprises consistently, analysts keep raising their estimates, traders become more confident in the company, driving the share price higher.

    What is Stock Sentiment?

    Stock Sentiment refers to how people speculating about the stock or what kind of trading position investors are often taking.

    There are different kinds of sentiments you can find online for a company, this includes Investor Sentiment (Percentage of investors buying or selling), News Sentiment (Is the company getting positive or negative impressions from the Press?), Social Sentiment (The overall trends about the company in social media, is it negative or positive?).